GE HealthCare Technologies Inc. $GEHC Stock Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 56.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 371,013 shares of the company’s stock after acquiring an additional 133,360 shares during the quarter. Jefferies Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $24,253,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. NBH Bank bought a new position in GE HealthCare Technologies during the second quarter valued at approximately $26,000. Provenance Wealth Advisors LLC grew its holdings in GE HealthCare Technologies by 401.0% during the 3rd quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock valued at $32,000 after buying an additional 393 shares in the last quarter. Global Assets Advisory LLC purchased a new position in GE HealthCare Technologies during the 1st quarter valued at approximately $37,000. Fortitude Family Office LLC increased its stake in GE HealthCare Technologies by 249.1% in the 3rd quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock worth $39,000 after acquiring an additional 426 shares during the last quarter. Finally, Aberdeen Wealth Management LLC bought a new stake in GE HealthCare Technologies in the 2nd quarter worth approximately $44,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on GEHC. Barclays upped their price objective on GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 29th. Needham & Company LLC reiterated a “buy” rating and set a $93.00 target price on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Royal Bank Of Canada raised their target price on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. Hovde Group assumed coverage on shares of GE HealthCare Technologies in a research report on Friday, July 17th. They issued a “market perform” rating and a $14.00 price target on the stock. Finally, Citigroup boosted their price target on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the stock a “neutral” rating in a research report on Thursday, October 29th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.17.

GE HealthCare Technologies Stock Down 1.3%

Shares of NASDAQ GEHC opened at $82.60 on Thursday. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The firm’s 50-day moving average price is $70.06 and its 200-day moving average price is $70.09. The stock has a market capitalization of $37.35 billion, a price-to-earnings ratio of 17.43, a P/E/G ratio of 2.11 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. The company had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $1.07 earnings per share. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date is Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.38%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.